Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C, Hydrocortisone and B Complex in Septic Patients
NCT04197115Phase 3Completed
- Sponsor
- IMSS Hospital General de Zona 11 Piedras Negras
- Start
- Sep 2019
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, open-label trial of ascorbic acid, hydrocortisone and Complex B in sepsis and septic shock (2 arms), sponsored by IMSS Hospital General de Zona 11 Piedras Negras. Primary endpoints: Difference in hospital mortality at 1 year and Difference in Intensive Care Unit Mortality at 1 year. Started Sep 2019; status: completed.
02
Drugs
ascorbic acidhydrocortisoneComplex B
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT04197115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197115.